Press Release(58)
Date: 13 Oct, 2019
Apollo Hospitals Navi Mumbai is the first hospital in Western India to successfully perform 25 Paediatric Live...
Apollo Hospitals, Navi Mumbai has achieved s a significant landmark, with the completion of 25 Paediatric Liver Transplants. A major milestone for the medical fraternity in Western India, the paediatric liver transplant program at Apollo Navi Mumbai took off two years ago at a time when children with end-stage liver disease had no comprehensive facility or access to advanced pediatric liver transplantation programmes in the city of Mumbai. The transplants have been successfully carried out at subsidized costs with a more than 90% success rate that compares with the best in the world.The transplants at Apollo Hospitals Navi Mumbai have given new hope to the families of young patients who find it challenging to meet the medical expenses of liver-related illness and liver transplantation costs. Apollo Hospitals Navi Mumbai, with its experienced transplant team and a world-class healthcare facility, provides an economically viable option for life-saving transplants.Dr Darius F Mirza, Consultant, HPB and Liver Transplant Surgery, Apollo Hospitals Navi Mumbai said, “The Apollo Hospital’s pediatric liver transplantation programme is staffed with experienced pediatric liver transplant surgeons and has success rates that are comparable to the best in the world. With well-equipped infrastructure and skilled pre and post-operative management teams, the risk to both donor and recipient are minimized to ensure a successful outcome. Today, with advances in surgical technique, immunosuppression, and post-operative aftercare, paediatric liver transplantation is a safe proven procedure.”“In liver transplant surgery, a diseased liver is replaced with a healthy liver from a donor. A liver transplant is advised for children with serious liver problems who will not be able to survive without a new donor liver. A living donor will be a family member. Since the liver is the only organ in the body that can replace or regenerate lost or damaged tissue, people who donate part of their liver can have healthy lives with the liver that is left, as the donor’s liver will grow back to normal size after surgery. The transplanted part received by the child also grows to normal size in a few weeks,” explained Dr Mirza.Dr Aabha Nagral, Consultant, Hepatology (Adult & Pediatrics), Apollo Hospitals Navi Mumbai spoke on the common indications for a paediatric liver transplant. She said, “The most common indication for a liver transplant is biliary atresia, a rare disease of the liver and bile ducts that occurs in infants and results in blockage of the bile flow from the liver to the gallbladder, causing damage to the liver cells. Other causes of childhood acute and chronic liver failure include inherited liver diseases. In children with serious dysfunction of the liver and end-stage liver disease, a liver transplant is the only solution. Timing of the liver transplant in a paediatric patient is important and is influenced by many factors including the age, the underlying liver disease, and past medical and surgical history. A multi-disciplinary team assesses the child and gives their input for the management.”Dr. Vikram Raut, Consultant, Liver Transplant Surgeon, Apollo Hospitals Navi Mumbai elaborated on how the team has achieved high success rates which are on par with international transplant success rates. He said, “Evaluation and selection of the donor and patient are critical. The challenge of matching the size of the donor liver for the paediatric patient is overcome by the use of techniques such as reduced, split, and living donor related liver transplantation. In a living-donor transplant, an organ or portion of liver is removed from a living person and placed in the patient whose organ is no longer functioning properly. Most of the living donors are discharged within a week and can resume their daily activities in 4 to 6 weeks. Also, with well-equipped infrastructure and an experienced team for pre and postoperative management, the risk to both donor and recipient can be minimized.”Mr. Santosh Marathe, COO & Unit Head, Apollo Hospitals Navi Mumbai said, “We are proud to be the first healthcare facility in Western India to have achieved this landmark of 25 paediatric liver transplants. The Apollo Hospitals Group has always created landmarks in healthcare, and the completion of 25 paediatric liver transplants in a short period of two years after starting the program is further evidence of the hospital group’s leadership in advanced healthcare that lays down the benchmark for accessible and affordable world-class healthcare in India. The hospital supports and performs liver transplant surgery at multiple centres across Maharashtra, including Apollo Hospitals, Nashik and Jehangir Hospital, Pune. The transplant unit has one of the most advanced pediatric intensive care units with a highly qualified intensivist team. The pediatric liver transplant programme at Apollo Hospitals, Navi Mumbai has also seen significant fund raising initiatives through crowd funding, thus reaching out to a larger strata of society and providing relief, treatment to the deserving children. Our achievement gives us the confidence to continue to aspire to deliver the best and advanced healthcare to the people of Western India.”
Date: 29 May, 2026
Apollo Hospitals Chennai Performs World’s First Robotic Cancer Surgery for Lymph Node Removal Using Hugo RAS P...
The uniqueness of performing the surgery lies in the lateral approach, which accesses the operative field from the side of the thigh rather than the middle.With the addition of this VEIL procedure for lymph node removal, the hospital has now completed the full spectrum of robotic uro-oncology procedures using the Hugo RAS System.Chennai, 27 May 2026: Apollo Hospitals Chennai, a leader in robotic-assisted cancer care, has performed the world’s first Video Endoscopic Inguinal Lymphadenectomy (VEIL) using the Hugo Robotic-Assisted Surgery (RAS) system through a lateral approach, a minimally invasive technique that accesses the groin lymph nodes from the side of the thigh rather than the middle. The patient, a 40-year-old man diagnosed with penile cancer, made an excellent recovery following the surgery, with no major post-operative complications. Inguinal lymph node removal is a well-established procedure performed when cancers such as penile, vulval, and vaginal cancer spread to the lymph nodes in the groin. Traditionally, the surgery is carried out through an open approach involving large incisions in the groin, which can sometimes damage the skin and lymphatic channels, leading to wound-healing complications and leakage of lymph fluid after surgery.However, outcomes are often improved when the procedure is performed using the minimally invasive, camera-guided VEIL technique on robotic platforms. In robotic VEIL surgery, surgeons operate through very small incisions using precise robotic instruments and enhanced visual control, resulting in less disturbance to the skin and surrounding tissues. The approach also significantly reduces post-operative lymph leakage compared to conventional open surgery. Apollo Hospitals has been using the Hugo RAS System to perform a wide range of robotic uro-oncology surgeries involving the prostate, kidney, and bladder. With the addition of this VEIL procedure for lymph node removal, the hospital has now completed the full spectrum of robotic uro-oncology procedures using the system.Speaking about the milestone, Dr. Ilankumaran Kaliamoorthy, CEO, Apollo Hospitals, Chennai Region “Apollo’s commitment to advanced medical technology and innovation continues to reach new heights every day. I am truly happy and grateful to be part of a progressive healthcare institution that remains dedicated to clinical excellence and improving patients’ quality of life through worldclass care.” Dr. N Ragavan, Senior Consultant – Urologist, Uro-Oncologist and Robotic Surgeon, Apollo Hospitals Chennai, said: “This achievement is the result of months of meticulous planning, clinical precision, and collaborative teamwork. Performing the world’s first robotic VEIL surgery using the Hugo RAS platform through the lateral approach was both challenging and rewarding. Every milestone in advanced robotic surgery comes with continuous learning, dedication, and the collective effort of highly skilled teams committed to pushing the boundaries of medical excellence. We are proud that this success will help improve patient outcomes and further strengthen the future of minimally invasive cancer care.” Dr Madhav Tiwari, Consultant - Urologist, Uro-Oncologist and Robotic Surgeon, Apollo Speciality Hospitals, Teynampet, Chennai, added: “Patient recovery shows the potential of this approach and its effectiveness. While cancers requiring inguinal lymph node removal, such as penile cancer, are relatively rare, they often require highly specialised surgical intervention. Advanced robotic-assisted procedures like VEIL are helping improve recovery outcomes significantly by reducing complications, minimising surgical trauma, and enabling faster healing. Increased awareness and timely diagnosis remain essential for achieving better treatment outcomes.”The surgery was successfully carried out by a multidisciplinary team led by Dr N Ragavan and Dr Madhav Tiwari, with anaesthesia support led by Dr Pradeep Chiruvar. The patient made an excellent recovery following the procedure. The successful treatment is another step toward the future of precision-driven and technologically assisted cancer care.
Date: 25 May, 2026
Apollo Hospitals Pune Celebrates Mother’s Day with Grand Launch of “Apollo Nest – Journey to Motherhood"
Apollo Hospitals celebrated Mother’s Day with warmth, gratitude, and inspiration by hosting a special event dedicated to honoring mothers and their incredible contribution to society. The event brought together mothers from across Pune for an evening filled with celebration and healthcare awareness. The celebration was graced by distinguished chief guests who have inspired society through their achievements and dedication:Dr. Sunita Pote – a medical professional, and Director of Mira Nursing Home, recognized for her contribution to healthcare and community welfare.Mrs. Shila Daware – India’s first lady auto driver, honored with the Rashtrapati Puraskar and featured in the Limca Book of Records for her remarkable achievements and inspiring journey of women empowerment.Mrs. Seema Chandekar – mother of renowned actor Siddharth Chandekar, appreciated for representing the strength, values, and nurturing spirit of motherhood. The guests were felicitated for their inspiring journeys and their ability to balance motherhood, career, and social responsibilities, serving as role models for women across generations.The event featured an inspiring address by Dr. Manisha Karmarkar, CEO of Apollo Hospitals Pune, who spoke about the strength, resilience, and unconditional love of mothers. Her heartfelt speech highlighted the importance of supporting women throughout every phase of motherhood and family life.A key highlight of the celebration was the grand inauguration of “Apollo Nest – Journey to Motherhood: Guiding You Through Every Kick and Cuddle,” a comprehensive ANC (Antenatal Care) program specially designed for mothers-to-be.The Apollo Nest initiative was officially unveiled on stage in the presence of healthcare experts, dignitaries, mothers, and members of the Apollo team. The program aims to provide holistic support and expert guidance throughout pregnancy and early motherhood.The expert team behind Apollo Nest includes:Dr. Ruchi Thakur – Gynecology & Obstetrics Dr. Shirsh Kankariya – Head of Pediatrics DepartmentDr. Abhijeet Bagde – Pediatrics & Head of PICUDr. Vishal Kole – NeonatologistDieticians Lactation ConsultantsPsychologistsPhysiotherapists Each expert shared valuable insights about the Apollo Nest program and explained how the initiative will support expecting mothers with comprehensive medical care, nutritional guidance, emotional wellness support, new-born care education, lactation counselling, and physiotherapy assistance.The event also featured a joyful cake-cutting ceremony where mothers-to-be and Apollo team members came together to celebrate the spirit of motherhood and the successful launch of Apollo Nest.The celebration also included a fun carnival with exciting activity stalls featuring games, fashion, nail art, eye makeup, and DIY Mother’s Day card-making activities. Mothers enthusiastically participated and enjoyed the vibrant and joyful atmosphere of the event.
Date: 07 May, 2026
Launch of Centre for Venous Disorders at Apollo Hospitals, Chennai
Chennai, 7 May 2026: In a major move forward in delivering high-quality and advanced vascular care, Apollo Hospitals announced the launch of the Centre for Venous Disorders at its flagship hospital on Greams Road. This centre aims at providing comprehensive treatment for all types of venous disorders through a patient-centered approach. The newly launched centre brings together all the specialisations of vascular surgery, radiology, dermatology, and wound care under one roof to provide patients with seamless access to diagnosis, treatment and follow-up. The centre’s approach is highly focused on efficiency and accuracy to facilitate same-day consultations, fast diagnostics, and minimal invasive day-care procedures.The Centre is equipped with advanced imaging systems and modern treatment technologies, treating conditions such as varicose veins, deep vein thrombosis (DVT), venous ulcers, bleeding, and chronic venous insufficiency. The patients benefit from shorter hospital stays, quick healing, and better clinical outcomes.Speaking on the occasion, Dr Ilankumaran Kaliamoorthy, CEO of Apollo Hospitals, Chennai Region, said, "With the launch of the Centre for Venous Disorders, we have made significant progress in tackling a group of disorders which often go undiagnosed and inadequately treated. With our multidisciplinary approach and advanced technology, we aim to provide our patients with timely, efficient and minimally invasive treatment, thereby improving quality of life and long-term outcomes.”Dr Balaji, Senior Consultant & Vascular Surgeon, Apollo Hospitals, Greams Road, Chennai said, “While many venous disorders are considered merely cosmetic in nature, they have a great impact on mobility and overall well-being if not treated promptly. Diagnosis is key here, as is intervention. Through this centre, we are able to provide treatment that is precise, minimal invasive and results in quick recovery and lasting results.”Dr Rajarajan Venkatesan, Senior Consultant & Vascular Surgeon, Apollo Hospitals, Greams Road Chennai, added, “Many patients have complications like ulcers or blood clots (thrombosis) that could have been prevented if they had come earlier. Our approach is not only about treating the condition, but on comprehensive evaluation, risk assessment, and long-term management of the condition so it does not recur.”The launch was also attended by senior leadership and clinical experts, including Mr Naveen, CEO, Apollo Hospitals, Greams Road and Dr Anil, DMS, Apollo Hospitals, Cluster 1, Chennai.The Centre for Venous Disorders is designed to provide patients with Comprehensive Care Approach services through early screening and risk assessment, advanced imaging and same-day diagnostics, minimally invasive procedures including laser and endovenous therapies, wound care and ulcer management, long-term follow-up and lifestyle modifications.Through this approach to venous health, Apollo Hospitals further continues to expand its commitment towards providing specialised, quality healthcare services and improved patient outcomes.For Appointments Click Here
Date: 27 Apr, 2026
Apollo Hospitals strengthens India’s next‑generation healthcare infrastructure with the launch of its 76th hos...
– 400-bedded smart hospital in Financial District, strengthens India’s leadership in accessible, technology-led healthcare –Hyderabad, April 27 2026: Apollo Hospitals Group today strengthened India’s rapidly expanding healthcare infrastructure with the launch of its 76th hospital in the country. The 400‑bedded, next‑generation smart hospital is located at the city’s Financial District. Part of Apollo’s pan-India network delivering complex and advanced care at scale, the new facility reflects the Group’s long-term commitment to building accessible, technology-led healthcare systems across India, while reinforcing the country’s position as a global destination for high-quality medical care. The hospital was inaugurated by the Hon’ble Chief Minister of Telangana, Mr. Revanth Reddy. Dignitaries present at the event also included Sri Damodar Rajanarsimha, Hon’ble Minister for Health, Medical and Family Welfare, Government of Telangana and Sri Arekapudi Gandhi, Member of Telangana Legislative Assembly.Apollo Hospitals, Financial District is designed as a digitally integrated, intelligent care ecosystem where technology enables seamless coordination across the patient journey. A unified digital platform, AI-enabled scheduling, and real-time clinical connectivity ensure faster, more precise, and continuous care. The hospital incorporates advanced clinical capabilities such as the Arthrex Pano Scope for enhanced, multi-angle visualisation in minimally invasive procedures, and VALD technology for objective assessment of strength, movement, and rehabilitation, supporting more accurate diagnosis and personalised treatment pathways. Imaging is further strengthened by the uMR Omega, an ultra-wide bore 3.0T MRI with end-to-end AI-enabled workflows, accelerated scan times, noise-reduced imaging, and enhanced in-bore patient comfort. Its advanced ICU infrastructure, with dedicated nursing attention at every bed, further strengthens critical care outcomes. This is complemented by a biophilic, patient-centric design that enhances comfort and healing for patients across all age groups.Dedicating the hospital of gratitude, Dr. Prathap C Reddy, Founder & Chairman - Apollo Hospitals Group, said, “When we build a hospital, we are building far more than infrastructure—we are building hope. This institution is rooted in gratitude—for the countless lives that have allowed us to learn, serve, and grow. It is our way of giving back, by creating a space where every patient is treated with compassion, every caregiver is empowered with the best tools, and every life is valued with dignity.”Over 40 years, Apollo has not merely built hospitals - it has built a healthcare nation. Apollo has saved millions of lives, trained generations of clinicians, and placed India on the global map as a destination for world-class medical care. Dr. Sangita Reddy, Joint Managing Director - Apollo Hospitals, added, “The 76th hospital is not just a milestone - it is a declaration that our mission of providing quality healthcare to all will continue. With our new smart hospital in Hyderabad’s Financial District, we are reaffirming India’s leadership in building next-generation healthcare systems. By embedding intelligence across every layer of care - from diagnostics to recovery – we are bringing together advanced technology and Apollo’s legacy of clinical excellence. This facility will strengthen Hyderabad’s position as a global destination for complex care, while making world-class healthcare more accessible to every citizen.”On the launch of Apollo’s 5th hospital in the city, Ms. Upasana Konidela, Vice Chairperson CSR, announced that 10,000 free health screening check-ups will be conducted for the Nanakramguda community every Sunday. (For details, call 040-23606666) She said the new Smart Hospital reflects Apollo’s commitment to advanced, patient-centric care backed by decades of expertise. It features a highly skilled medical team, global safety standards, ethical practices, and continuous staff upskilling. With convenient access, minimal wait times, and seamless digital services, the hospital aims to enhance overall patient experience and deliver quality healthcare.Highlighting the regional impact, Mr. Tejesvi Veerepalli, Regional CEO – AP/Telangana, AHEL, said, “This is not just a hospital, it is a holistic, patient-centric health system built for the future that will further strengthen Hyderabad’s emergency response ecosystem and advance our commitment to the ‘golden hour’. With connected ambulances and our dedicated emergency number 1066, care begins even before the patient reaches the hospital, saving critical time and lives.”With this launch, AHEL reinforces that healthcare must be faster, smarter, and within the reach of every life.
Date: 17 Apr, 2026
Dr Ilankumaran Kaliamoorthy appointed Chairperson of CAHO’s Healthcare Institutions Division
Appointment reinforces leadership in advancing patient safety, quality care, and accreditation across India’s healthcare ecosystemChennai, April 2026: The Consortium of Accredited Healthcare Organizations (CAHO) has appointed Dr Ilankumaran Kaliamoorthy, Chief Executive Officer, Apollo Hospitals - Chennai Region, as Chairperson of its Healthcare Institutions Division for the 2026–2028 term. CAHO, a leading body focused on advancing patient safety and quality standards across healthcare institutions in India, brings together accredited hospitals and healthcare providers to drive best practices, clinical governance, and system-wide improvements.In his role as Chairperson of the Healthcare Institutions Division, Dr Kaliamoorthy will work closely with member institutions to strengthen quality frameworks, promote standardisation of care, and enable knowledge-sharing across the ecosystem. The focus will be on building scalable, sustainable approaches to accreditation, patient safety, and clinical excellence across diverse care settings.Dr Kaliamoorthy brings extensive experience in hospital administration and clinical operations, with a strong track record in driving quality-led healthcare delivery. At Apollo Hospitals, Chennai Region, he has led initiatives focused on clinical outcomes, operational efficiency, and patient-centric care models.Commenting on the appointment, Dr Ilankumaran Kaliamoorthy said, “This is an important moment for healthcare in India, where the focus is increasingly shifting towards measurable quality, patient safety, and accountability across institutions. CAHO has played a critical role in shaping this agenda, and I look forward to working with member organisations to strengthen systems that deliver consistent, high-quality care. The priority will be to translate standards into everyday practice and support institutions in building capabilities that are both scalable and sustainable.”The appointment comes at a time when healthcare systems across India are placing greater emphasis on accreditation, transparency, and continuous quality improvement, with industry bodies like CAHO playing a key role in enabling alignment and progress across institutions.For more information, Click here https://www.apollohospitals.com/apollo-in-the-news
Date: 02 Mar, 2026
India’s first adaptive deep brain stimulation performed at Apollo Hospitals Chennai
Milestone highlights the shift toward real-time, personalised neuromodulation in Parkinson’s treatmentAnnounced on the occasion of World Parkinson’s Day, underscoring the need for awareness and timely access to advanced therapiesCHENNAI, India – 11 April 2026: Apollo Hospitals, Chennai announces a major milestone in the treatment of Parkinson’s disease in India, the country’s first clinical activation of Adaptive Deep Brain Stimulation (aDBS). The procedure was carried out on 2 March 2026 by Dr. Vijayashankar Paramanandam, Dr. Arvind Sukumaran, and their team. The programme is led by clinicians with advanced international fellowship training in movement disorders neurology and functional neurosurgery. A recent British Medical Journal study underscores the rising burden of Parkinson’s disease in India, with an estimated 2.8 million people expected to be living with the condition by 2050 (range 2.3–3.5 million), second only to China and accounting for nearly one-tenth of global cases. South Asia is projected to contribute nearly 6.8 million cases overall. Globally, the Parkinson’s population is expected to reach 25.2 million—up over 112% from 2021 levels—with India alone projected to see a 160–180% increase. Current global prevalence stands at 267 cases per one lakh people. The milestone builds on the hospital’s established Deep Brain Stimulation (DBS) programme, developed through sustained experience in movement disorders and functional neurosurgery. This follows an initial period of clinical follow-up to assess the patient’s response to the treatment. Conventional DBS has transformed care for appropriately selected Parkinson’s patients by delivering continuous electrical stimulation to targeted areas of the brain. Adaptive DBS fine tunes it by introducing a more responsive approach, adjusting stimulation in real time based on the patient’s own brain signals. This approach is supported by sensing-enabled neurostimulation systems, including those developed by Medtronic, allowing therapy to better align with fluctuations in symptoms across the day. Adaptive DBS is an important advance in Parkinson’s therapy,” said Dr. Vijayashankar Paramanandam, Senior Consultant Neurologist & Movement Disorders and DBS Specialist, Apollo Hospitals, Greams Lane-Chennai. “Adaptive DBS represents the next major evolution from conventional, continuous DBS therapy. By actively monitoring the brain’s unique electrical signals, the system responds instantaneously, delivering the precise amount of stimulation exactly when it is needed. This effectively smooths out unpredictable symptoms and improves the quality of life , bringing us closer to truly personalized DBS care.” “In any new technology, what matters is patient benefit,” said Dr. Arvind Sukumaran, Senior Consultant Neurosurgeon, Apollo Hospitals, Greams Lane- Chennai. “Following activation, programming and clinical follow-up over a month, we have seen encouraging early response in terms of stability throughout the day. That is a meaningful outcome in Parkinson’s, where fluctuation is often the most challenging aspect to manage.” The patient, a 62-year-old male, also reported meaningful improvement. “I feel more stable through the day, and that makes a real difference to daily life,” he said. Parkinson’s disease is a progressive neurological condition that affects movement, independence, and quality of life. Patients who have lived with the disease for several years, require multiple medications, and experience significant “off” periods or dyskinesias may benefit from timely referral for advanced therapies such as DBS. Observed every year on April 11, World Parkinson’s Day highlights the need for greater awareness, early diagnosis, and improved access to care. This development reflects the growing role of advanced, physiology-guided therapies in addressing unmet needs in Parkinson’s management in India. For Appointments, Click Here
Date: 12 Feb, 2026
Apollo Hospitals Achieves 8,000+ Robotic Surgery Milestone, Building Tamil Nadu's Most Advanced Surgical Ecosy...
- Patients benefit from up to 50% less blood loss, and faster recovery compared to conventional surgery.Chennai, 12 February 2026: Apollo Hospitals announced the successful completion of over 8,000 robotic-assisted surgeries across multiple specialities, marking a significant milestone in its commitment to precision-led, patient-centric surgical care. With this achievement, Apollo Hospitals has established Tamil Nadu's largest multi-platform robotic surgery programme and the most comprehensive robotic surgical ecosystem in Chennai, significantly expanding access to advanced surgical precision for patients across the state. Apollo Hospitals has built a uniquely integrated robotic ecosystem by deploying advanced platforms, including the da Vinci Xi, MAKO, HUGO RAS, SSI Mantra, and Globus ExcelsiusGPS surgical systems. This multi-platform approach enables surgeons to select the most appropriate technology based on clinical indication, procedural complexity, and individual patient needs, thereby enhancing surgical accuracy, safety, and outcomes. Dr Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Limited said, “At Apollo Hospitals, every pivotal decision is always centred around enhancing patient care. Therefore, over a decade ago, robot assisted surgery was introduced into the Apollo ecosystem, as we firmly believed that our patients deserved the highest standards of precision, safety, and recovery outcomes on par with the finest available in the world. The trust that patients place in us is deeply valued, and it is this responsibility that has guided our careful, outcome-driven integration of robotics. Further, achieving a landmark milestone of 8,000 robotic surgeries in Chennai, reflects the rigor of our clinical systems, the skill of our surgeons and a mature, multi-platform ecosystem which empowers them allows them to match the right technology to the right patient, ensuring that innovation remains clinically meaningful, ethically grounded, and firmly patient-first.”Ms. Sindoori Reddy, Director - Strategy, Apollo Hospitals, added, "Our robotic program is built on a simple yet powerful principle of using the right technology for the right patient, every time. By investing across multiple platforms, we have created a future-ready surgical ecosystem that supports surgeons, improves consistency, and delivers measurable outcomes. As we look to the future, innovations such as the world’s first portable robotic surgeon console are redefining what is possible - enabling expertise to move beyond physical boundaries and expanding access to advanced care. The true impact lies not in the numbers alone, but in improved recovery, safety, and quality of life for our patients." Robotic-assisted procedures at Apollo Hospitals span a wide range of specialities, including Urology, Gynecology, General and Laparoscopic Surgery, Colorectal and Thoracic Surgery, Orthopedics and Joint Replacement, Oncology, and Cardiac Sciences. This program provides a hospital-wide strategy where advanced technology, standardised clinical protocols, and continuous outcome monitoring are seamlessly integrated into everyday surgical practice.To date, over 8,000 robotic surgeries have been performed across specialities, with 30–40% of complex procedures in select departments now conducted robotically, among the highest adoption rates in the state. Clinical outcomes from robotic-assisted procedures indicate up to 50% lower blood loss, and faster recovery and return to daily activities, depending on the procedure, compared to conventional surgery. Apollo Hospitals has also made sustained investments in surgeon training, credentialing, and continuous outcome tracking, resulting in one of the largest and most experienced robotic surgical teams in the state. Robotic surgery volumes continue to grow steadily, driven by strong clinical outcomes and increasing patient confidence.As part of its ongoing commitment to awareness and understanding of next-generation surgical technologies, Apollo Hospitals hosted a robotic showcase open to the public, with a special focus on medical college students. Doctors, students, influencers, and media representatives interacted with surgeons and experienced the robotic platforms firsthand, reinforcing Apollo's commitment to education, transparency, and innovation in healthcare.
Date: 22 Jan, 2026
India’s most Comprehensive Heart and Lung Transplant Program gives critically ill patients a second chance at ...
Over 600 heart and lung transplants and 1,000 ECMO cases mark a major national milestone in advanced critical careConsistent, high-survival outcomes position Apollo Hospitals, Chennai as India’s leader in advanced heart and lung failure management Chennai, 22 January 2026: Apollo Hospitals, Chennai continues to set national benchmarks in the treatment of advanced heart and lung disease, driven by one of India’s most comprehensive heart, lung, and ECMO-supported transplant programs. The transplant team, with significant national and international experience, have performed 600+ heart and lung transplants, managed over 2,000 transplant patients, 1,000+ Extracorporeal Membrane Oxygenation (ECMO) cases, along with 250+ Left Ventricular Assist Devices (LVAD) procedures and 250+ Chronic Thromboembolic Pulmonary Hypertension (CTEPH) interventions. The multidisciplinary heart-lung transplant and MCS program at Apollo expertly manages patients with end-stage heart and or lung failure, offering personalised solutions for those who no longer respond to maximal medical therapy. Be it a stabilising, bridging or definitive treatment with transplanting hearts and lungs, or implanting durable mechanical cardiac pumps for failing hearts, our patients are supported through a continuum of focused and evidence-based care. The team also offers comprehensive solutions for even the most complex cardiopulmonary conditions, such as the gold standard treatment of Pulmonary Endarterectomy (PEA) for appropriate patients with CTEPH, where the chronic blood clots in the lung arteries are removed surgically. The press conference held to mark this milestone featured patients from different age groups and levels of illness severity, who shared how their lives were transformed by the program. Among them were Mr. Raja Sivagurunathan (59), who survived a critical phase on ECMO support for 48 days before undergoing an emergency double-lung transplant; Mr. B. Saravanan (45), who developed sudden and severe lung failure and was supported on life-saving machines for two weeks until a successful lung transplant; and Mr. Radhae Shyam Raghuvanshi (72), whose condition worsened abruptly and who was airlifted to Chennai before receiving a double-lung transplant after advanced support. Commenting about ECMO and Transplantation, Dr. Srinivas Rajagopala, Senior Consultant & Clinical Lead - Pulmonology, Sleep Medicine and Lung Transplant, Apollo Hospitals Chennai said, “These outcomes demonstrate how early and appropriate use of ECMO can fundamentally alter the course of severe lung failure. It provides a vital bridge allowing time for stabilisation, informed decision-making, and preparation for lung transplantation. Success lies in constant vigilance, multidisciplinary teamwork, and highly personalized care. Our goal is always meaningful recovery, not merely short-term survival.” Dr. R Ravi Kumar, the Clinical Lead for Heart Failure & Transplant Cardiology, Apollo Hospitals Chennai, described how Apollo Hospitals was achieving superior outcomes for the sickest patients with end-stage heart failure. “The team at Apollo Hospitals, with its evolving national program, is already delivering a unique clinical service that is succeeding in reducing both time to transplant and mortality on the waitlist. We hope to repeat this at other Apollo Hospitals facilities beyond Chennai and Bangalore”. Dr. Kumud Kumar Dhital, Head of Heart and Lung Transplantation at Apollo Hospitals, Chennai, emphasized “Patients suffering from advancing heart and lung failure, with escalating medical therapy and declining quality of life, deserve to be informed of the transplant options at a far earlier stage. Outcomes improve significantly when patients are referred early and managed with strong, protocol-driven hospital care. Age itself is not a limitation - what matters is careful evaluation, optimization, meticulous surgery, expert after-care in the ICU, and life-long post-discharge continuity of care so as to maximize chances of long-term survivorship.” Dr. IIankumaran Kaliamoorthy, CEO – Chennai Region, Apollo Hospitals also participated in the press conference. As India’s burden of advanced heart and lung disease continues to rise, Apollo Hospitals remains at the forefront of comprehensive cardiothoracic transplantation, combining innovation, expertise, and compassionate care- proving that even the most critical organ failure can be transformed into a second chance at life. Apollo Hospitals delivers 360-degree care through an integrated, multidisciplinary model involving cardiology, pulmonology, cardiothoracic surgery, anaesthesia, critical care, transplant coordination, rehabilitation, and seamlessly coordinates this with post-discharge and long-term follow-up. The program’s focus extends beyond survival to restoring functional independence and quality of life for patients while fully informing and supporting their families. ECMO serves as a vital life-support technology within this ecosystem. This mechanical support temporarily takes over the function of the heart and/or lungs when conventional therapies fail. By oxygenating blood outside the body, ECMO allows failing organs to rest and recover or acts as a crucial bridge to recovery or transplantation. The program integrates VV-ECMO for lung support, VA-ECMO for cardiac and combined heart-lung failure. LVADs in the form of implantable and mechanical heart pumps are offered to suitable candidates as durable alternatives or bridge to heart transplantation.
Date: 22 Oct, 2025
Spike in Breast Cancer Cases among Women between the ages of 35-50 years, Say Experts at Indraprastha Apollo H...
Approximately 50% women reporting cases of breast cancer are between the age of 35-50 yearsPandemic induced hesitancy to visit hospitals, have increased the percentage of women reporting advanced stages of breast cancerBreast cancer is the most common form of cancer in women, it accounts for almost 30% of the entire cancer burden reported among women. With limited awareness and hesitancy towards preventive diagnosis, 1 in every 20 women is diagnosed with this cancer. With various misconceptions and lack of awareness regarding early diagnosis of breast cancer and related treatment, there has been a spike in the number of cases of breast cancer, among women between the ages of 35 to 50 years.It is perhaps due to this lack of awareness that most women in India get diagnosed with the breast cancer at its advanced stages and thus have to undergo all the related treatment modalities that are both physically and mentally challenging. Due to pandemic induced hesitancy to visit hospitals a lot of women have delayed treatment or ignored early sign and symptoms, hence adding to the evident spike in cases.Dr Ramesh Sarin, Senior Consultant, Surgical Oncologist, Indraprastha Apollo Hospitals, New Delhi said, “Basis our records from past three years, we have observed that 50 % women reporting breast cancer and related manifestations have been between the age of 35 to 50 years. With our hospital based consultation data for breast cancer, it is found that though 53% of the reported cases are in the initial stages of cancer and 47% are in the advanced stages of cancer by a total of 20% in stage 4 and 27% in stage 3 cancer. The survival or cure rate falls drastically from early stage to advanced stages. In our own series, 90 % of women in stage 1 and 2 survive for more than 10 years while only 30% survive in stage 3 and 5% in stage 4. We need to increase the detection up to 70-80% in early stages of cancer by making women aware of the early signs and symptoms of breast cancer for achieving a better cure rate with proper management of the disease.The reasons for early age occurrence are varied and imprecise. It could be faulty genes inherited from parents, or history of breast or ovarian cancers in the close family. Certain lifestyle choices also contribute towards the risk of developing breast cancer in young women such as limited or lower amount of physical activity and increasing obesity and smoking. Excessive consumption of alcohol and oral contraceptives also have debatable association with increased risk of breast cancer in younger women. As a reason, women are highly advised to be watchful towards their sedentary lifestyle patterns and any newly observant signs of a breast cancer like a lump, discharge or discoloration of breasts.”An early detection can save a woman from undergoing chemo therapy, losing her breast and hair and experiencing related serious manifestations of the disease. Hence, there should be an increased awareness on the breast cancer along with a guided behavior for adequate weight management and correct diet and exercises with a self-responsibility of taking frequent self-examination and screening mammograms.About Indraprastha Apollo Hospitals:Indraprastha Apollo Hospitals, India’s first JCI accredited hospital, is a joint venture between the Government of Delhi and Apollo Hospitals Enterprise Limited. Commissioned in July 1996, it is the third super-specialty tertiary care hospital set up by the Apollo Hospitals Group. Spread over 15 acres, it houses 57 specialties with more than 300 specialists and more than 700 operational beds, 19 operation theatres, 138 ICU beds, round-the-clock pharmacy, NABL accredited laboratories, 24-hour emergency services and an active air ambulance service. Apollo Hospitals Delhi has the leading programme in kidney and liver transplant in the country. The first successful paediatrics and adult liver transplants in India were performed at Indraprastha Apollo Hospitals. The hospital is at the forefront of medical technology and expertise. It provides a complete range of latest diagnostic, medical and surgical facilities for the care of its patients. The Hospital has introduced the most sophisticated imaging technology to India with the introduction of 64 slice CT and 3 Tesla MRI, Novalis Tx and the integrated PET Suite. Indraprastha Apollo has also pioneered the concept of preventive health check programmes and has created a satisfied customer base over decades. The Hospital has been consistently ranked amongst the best 10 hospitals in India by The Week survey for the past few years.
Date: 13 Aug, 2025
Apollo Speciality Hospitals, Teynampet Transforms Emergency Care with Revolutionary Cath Lab Technology
Chennai, August 13, 2025: Apollo Speciality Hospitals, Teynampet, has launched its most advanced Cath Lab, a transformative addition to Chennai’s healthcare infrastructure. This system is a specialised treatment room where doctors perform highly complex, life-saving procedures without the need for open surgery, empowering clinicians to work with greater speed, precision, and patient safety across cardiology, neurology, and interventional oncology.The new facility was inaugurated by Hon’ble Minister for Tamil Development, Information & Publicity, Govt of Tamil Nadu, Thiru M.P. Swaminathan in the presence Mr. Harshad Reddy, Director, Group Oncology & International, Dr. Madhu Sasidhar, President & CEO, Apollo Hospitals and Dr. A.L. Narayanan, Clinical Lead and HOD, Interventional Cardiology, Apollo Speciality Hospitals.Mr. Harshad Reddy, Director, Group Oncology & International, Apollo Hospitals, said, “The launch of advanced Cath Lab marks yet another milestone in Apollo’s journey towards technology-driven, precision care. This facility gives our doctors enhanced capabilities, they can make better diagnosis, act faster in emergencies, and treat patients across cardiology, neurology, and oncology with unprecedented safety and precision. This advanced Cath Lab will enable patients to benefit from faster, minimally invasive interventions and improved outcomes.”Dr. A.L. Narayanan, Clinical Lead and HOD, Interventional Cardiology, Apollo Speciality Hospitals, Teynampet, said, “Our new Cath Lab represents the future of interventional medicine—safe, precise, and patient-centric. With superior imaging that functions like GPS for the human body and real-time navigation, we are now equipped to tackle some of the most challenging cardiac, neurovascular, and oncological cases with confidence and speed. The ability to visualise vessels and structures in such detail means we can perform complex interventions with smaller incisions, reduced radiation exposure, and faster recovery times. It is a significant step forward in ensuring timely, life-saving care for our community.”Positioned at the heart of the city, the new Cath Lab leverages high-resolution 3D imaging, advanced stent motion visualisation, comprehensive neurovascular support, and low-dose radiation technology to deliver fast, safe, and targeted care. Patients suffering from heart attacks, strokes, and complex vascular conditions, as well as certain cancers, can now receive critical treatment through minimally invasive procedures that require only small incisions or catheter insertions. The enhanced precision and reduced need for open surgery offer quicker recovery, improved outcomes, and the ability to save lives by acting swiftly in emergencies.
Date: 23 Aug, 2025
Indraprastha Apollo Hospitals New Delhi Launches Dedicated Living Will Clinic & Advance Medical Directives Cli...
New Delhi, 23rd August 2025: In a landmark initiative to empower individuals in making informed healthcare choices, Indraprastha Apollo Hospitals, New Delhi has launched dedicated Living Will Clinic. The clinic will guide people through Advance Care Planning (ACP), enabling them to document their medical treatment preferences, appoint trusted representatives, and ensure that their care reflects their personal values even in circumstances where they may be unable to communicate their wishes. The Living Will Clinic offers structured, end-to-end support including individual consultations, family meetings, legal documentation guidance, and assistance in nominating decision-making representatives. A core focus is helping individuals prepare a Living Will or Advance Medical Directive, a legally recognized document that safeguards autonomy by recording preferences on life-sustaining treatment, resuscitation, and quality of care. The clinic will be led under the leadership of Dr. (Prof) Sushma Bhatnagar, Clinical Lead and Senior Consultant, Pain, Palliative Medicine & Supportive Care, Indraprastha Apollo Hospitals, a globally acclaimed pioneer in palliative care, pain management, and end-of-life policy in India. With over three decades of clinical, academic, and policy contributions, including founding India’s Pain Policy and End-of-Life Care Policy at AIIMS and serving as President of the Indian Association of Palliative Care. In this initiative, Dr. Ipsita Pati, Attending Consultant, Pain, Palliative Medicine & Supportive Care, Indraprastha Apollo Hospitals, will be actively supporting the clinic and its patients. This initiative comes at a critical time when medical decisions are becoming increasingly complex and emotionally difficult for families in India. By offering professional, compassionate, and structured guidance, Apollo Hospitals aims to ease the burden on loved ones, reduce conflicts in crisis situations, and ensure that healthcare decisions are not only medically appropriate but also aligned with the patient’s dignity and values. Speaking on the occasion, Dr. (Prof) Sushma Bhatnagar, Clinical Lead and Senior Consultant, Pain, Palliative Medicine & Supportive Care, Indraprastha Apollo Hospitals, said: Healthcare is not only about treating illness, but also about respecting an individual’s dignity, voice, and values. Too often, families are left struggling with uncertainty during medical crises, not knowing what their loved one would have wanted. The Living Will Clinic has been created to address this gap. It empowers patients to record their wishes in advance, gives families peace of mind that they are making the right choices, and provides doctors with the confidence that they are acting in alignment with both medical ethics and patient values. This initiative marks a cultural shift in India’s healthcare system, placing compassion, autonomy, and dignity at the heart of medical decision-making. Through the Living Will Clinic, we want to assure people that their care will always remain on their terms.” With this launch, Indraprastha Apollo Hospitals reaffirms its commitment to bringing holistic and patient-first healthcare to India. By creating a safe and empathetic space for difficult but essential conversations, the hospital is setting a benchmark on how healthcare institutions can combine medical excellence with ethical, value-driven care.
Best Hospital Near me Chennai
